PLAZZI, Pier Vincenzo
 Distribuzione geografica
Continente #
NA - Nord America 1.621
EU - Europa 1.586
AS - Asia 544
SA - Sud America 5
OC - Oceania 3
Totale 3.759
Nazione #
US - Stati Uniti d'America 1.590
CN - Cina 455
FI - Finlandia 444
SE - Svezia 324
IE - Irlanda 279
UA - Ucraina 228
DE - Germania 158
TR - Turchia 63
IT - Italia 57
GB - Regno Unito 45
CA - Canada 31
BE - Belgio 23
AT - Austria 14
SG - Singapore 11
IN - India 10
AR - Argentina 5
IR - Iran 4
ES - Italia 3
AU - Australia 2
CZ - Repubblica Ceca 2
FR - Francia 2
NL - Olanda 2
EE - Estonia 1
HR - Croazia 1
KR - Corea 1
LT - Lituania 1
NZ - Nuova Zelanda 1
RO - Romania 1
RU - Federazione Russa 1
Totale 3.759
Città #
Chandler 307
Dublin 279
Jacksonville 273
Ann Arbor 134
Dearborn 127
Nanjing 86
Ashburn 85
Beijing 79
Princeton 55
Izmir 54
New York 52
San Mateo 50
Wilmington 36
Nanchang 30
Toronto 30
Hefei 29
Shanghai 28
Shenyang 28
Jinan 27
Hebei 24
Boardman 23
Bremen 23
Brussels 23
Helsinki 23
Des Moines 19
Kunming 18
Parma 17
Los Angeles 15
Vienna 14
Woodbridge 14
Grafing 12
Jiaxing 12
Changsha 11
Tianjin 11
Hangzhou 8
Norwalk 8
Ankara 7
Guangzhou 7
Auburn Hills 6
Augusta 6
Mordano 6
Seattle 6
Cordoba 5
Falls Church 5
Pune 5
Zhengzhou 5
Dallas 4
Fremont 4
Fuzhou 4
Fiorano Modenese 3
Houston 3
Madrid 3
Ningbo 3
Xian 3
Belluno 2
Chengdu 2
Collebeato 2
Huizen 2
Kocaeli 2
Lanzhou 2
Milan 2
Prague 2
Redmond 2
Reggio Nell'emilia 2
Sabz 2
Taiyuan 2
Wuhan 2
Ardabil 1
Baotou 1
Bari 1
Berlin 1
Birmingham 1
Bologna 1
Borås 1
Brisbane 1
Canberra 1
Changchun 1
Charlotte 1
Chongqing 1
Düsseldorf 1
Edinburgh 1
Fairfield 1
Florence 1
Haikou 1
Jaipur 1
Las Vegas 1
London 1
Madison 1
Maranello 1
Massa 1
Monmouth Junction 1
Mountain View 1
New Delhi 1
Niles 1
Paris 1
Qingdao 1
Quzhou 1
Singapore 1
Tallinn 1
Tappahannock 1
Totale 2.208
Nome #
Analysis of Structure-Activity Relationships for MT2 Selective Antagonists by Melatonin MT1 and MT2 Receptor Models 112
Azionifarmacologiche di composti alchilaminoalchilfenilbenzisotiazolici sul trattogastrointestinale 98
Comparison of the effects of structurally different H2-antagonists on acid and pepsin activity stimulated by dimaprit in conscious cats 97
Application of 3D-QSAR in the Rational Design of Receptor Ligands and Enzyme Inhibitors 95
The Role of HB-Donor Groups in the Heterocyclic Polar Fragment of H3-Antagonists. I. Synthesis and Biological Assays 92
Synthesis and 3D-QSAR Analysis of H3 Receptor Antagonists Containing a Neutral Heterocyclic Polar Group 90
2-N-Acylaminoalkylindoles: Design and Quantitative Structure-Activity Relationship Studies Leading to MT2-Selective Melatonin Antagonists 90
5-Benzylidene-hydantoins as new EGFR inhibitors with antiproliferative activity 85
Synthesis and biological assays of new H3-antagonists with imidazole and imidazoline polar groups 83
5-Benzylidene-hydantoins: synthesis and antiproliferative activity on A549 lung cancer cell line 81
Validation of a histamine H3 receptor model through structure–activity relationships for classical H3 antagonists 80
A New Potent and Selective Histamine H3-Receptor Antagonist, 4(5)-{2-[4(5)-cyclohexylimidazol-2-ylthio]ethyl}imidazole 79
Meccanismo d’azione di UPR 1024: un nuovo farmaco con attività antiproliferativa in cellule di carcinoma polmonare umano 78
Alchilammidi tricicliche: ligandi selettivi dei recettori melatoninergici MT1 e MT2 77
4-(1,2-benzisothiazol-3-)alkanoic and phenylalkanoic acids: synthesis and anti-inflammatory, analgesic and antipyretic activities 75
Tricyclic Alkylamides as Melatonin Receptor Ligands with Antagonist or Inverse Agonist Activity 74
Cyclohexylcarbamic Acid 3'- or 4'-Substituted Biphenyl-3-yl Esters of as Fatty Acid Amide Hydrolase Inhibitors: Synthesis, Quantitative Structure-Activity Relationships and Molecular Modelling Studies 73
Dibasic non-imidazole histamine H3 receptor antagonists with a rigid byphenyl scaffold. 73
HPLC detection ofthioperamide from biological samples and its determination in rat blood and brainafter systemic administration 72
Synthesis, biological activity, QSAR and QSPR study of 2/aminobenzimidazole derivatives as potent H3-antagonists 72
Antioxidant and cytoprotective activity of indole derivatives related to melatonin 71
Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity. 71
A Short and Efficient Synthesis of the Selective H4 Receptor Agonist 4-Methylhistamine 68
Indole-based analogs of melatonin: in vitro antioxidant and cytoprotective activities 66
Experimental and Theoretical Analysis of the Interaction of (±)-cis-Ketoconazole with b-Cyclodextrin in the presence of (+)-L-Tartaric Acid 66
Structure-Property Relationships on Histamine H3-Antagonists: Binding of Phenyl-substituted Alkylthioimidazole Derivatives to Rat Plasma Proteins 66
Sviluppo e caratterizzazione farmacologica di un nuovo potente e selettivo H3-bloccante istaminico non-tioureico 66
Hz-agonistiimidazolici: importanza della 2-amino sostituzione per 1'attivita farmacologica 66
Imidazole H3-antagonists: Relationship between Structure and Ex-vivo binding to Rat Brain H3-Receptors 65
Structural researcheson H^-agonists: the structures of the dipicrates of 2-(2-amino-4-imidazolyl)ethylamine, its 5-methyl derivative and N^f-dimeihyl-2-(2-am'mo-l,3-thiazol-5-yl)ethylamine 64
Ligands for the histamine H3-receptor: new potent antagonists of the 2-thioimidazole type 63
H3-antagonists: synthesis and activity of 2-amino-5-thiazolyl derivatives 63
Biological studies on 1,2-benzisothiazole derivatives. V. Antimicrobial properties of N-alkanoic, N-arylalkanoic and N-aryloxyalkanoic derivatives of 1,2-benzisothiazolin-3-one: QSAR study and genotoxicity evaluation 63
Pharmacological activities of two new histamine analogs 62
Three-Dimensional Quantitative Structure-Activity Relationship Studies on Selected MT1 and MT2 Melatonin Receptor Ligands: Requirements for Subtype Selectivity and Intrinsic Activity Modulation 61
Synthesis and biological evaluation of new non-imidazole H(3)-receptor antagonists of the 2-aminobenzimidazole series 61
null 61
H3-receptor antagonists: Synthesis and structure relationships of para- and meta-substituted 4(5)-phenyl-2-((2-(4(5)-imidazolyl)ethyl)thio)imidazoles 60
Synthesis, antioxidant activity and structure-activity relationships for a new series of 2-(N-acylaminoethyl)indoles with melatonin-like cytoprotective activity 60
Design, synthesis and SAR of alkylcarbamic acid aryl esters, a new class of fatty acid amide hydrolase inhibitors 58
Pharmacological profile of original potent H3 receptor antagonists 58
Studio di sostanze analoghe alDimaprit sulla secrezione gastrica "in vitro" 58
Histamine H3-antagonists: the basicity of the polar group in quantitative structure-activity and structure-property relationship 58
Rat protein binding and cerebral phospholipid affinity of the H3-receptor antagonist thioperamide 53
Auxin-like activity of 1,2-benzisothiazole derivatives 53
Influence of urea-equivalent groups in position 5 of 2-amino, 2-(1-aminoethylidenamino) and 2-guanidino thiazole derivatives on H3-receptor antagonist activity in gastric fistula cat 53
Synthesis and stability in biological media of 1H-imidazole-1-carboxylates of ROS203, an antagonist of the histamine H3 receptor. 51
Pharmacological characterization of H3 receptor antagonists with imidazole, thioimidazole and thioimidazoline polar groups in the side chain 51
The 1,2-dichloroethane/water versus the n-octanol/water system: more about intra- or intermolecular H-bond interactions 49
Melatonin 47
QSAR study on H3-receptor affinity of benzothiazole derivatives of thioperamide 45
Synthesis and Structure-Activity Relationships of FAAH Inhibitors: Cyclohexylcarbamic Acid Biphenyl Esters with Chemical Modulation at the Proximal Phenyl Ring 44
Melatonin Receptor Ligands: Synthesis of New Melatonin Derivatives and Comprehensive Comparative Molecular Field Analysis (CoMFA) Study. 44
Synthesis, Pharmacological Characterization and QSAR Studies on 2-Substituted Indole Melatonin Receptor Ligands 43
Synthesis and Structure-Activity Relationships of a Series of Pyrrole Cannabinoid Receptor Agonists 38
null 37
Antipyreticactivity of new compounds 4-(3-oxo-l,2-benzisothiazolin-2-yl)puenyialkanoicacids, their esters, amides and 1,1 dioxide derivatives 33
Are histamine receptors involved in the stimulant activities ofthiazolylethylamines supposed as cyclic models of dimaprit? 7
Totale 3.779
Categoria #
all - tutte 11.701
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.701


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201983 0 0 0 0 0 0 0 0 0 0 82 1
2019/2020842 121 105 65 11 78 95 122 16 108 27 37 57
2020/2021438 7 61 39 9 58 1 65 5 102 9 80 2
2021/2022320 6 2 3 28 12 26 41 44 22 22 27 87
2022/20231.177 146 125 80 92 107 148 19 63 345 18 27 7
2023/2024301 22 33 6 12 28 118 33 21 10 18 0 0
Totale 3.779